Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Lymphoma; Lymphoma, Non-Hodgkin Phase 1/Phase 2 ClinicalTrials
Lymphoma; Lymphoma, Non-Hodgkin Phase 1/Phase 2 ClinicalTrials
CONTENTS